Category:Cancer treatments
From WikiMD.com Medical Encyclopedia
 | Pages in this category should be moved to subcategories where applicable. This category may require frequent maintenance to avoid becoming too large. It should directly contain very few, if any, pages and should mainly contain subcategories. |
Wikimedia Commons has media related to
.
Subcategories
This category has the following 8 subcategories, out of 8 total.
A
C
E
I
R
S
T
V
Pages in category "Cancer treatments"
The following 200 pages are in this category, out of 396 total.
(previous page) (next page)3
A
- Abituzumab
- ABT-510
- Active immunotherapy
- Active surveillance
- Active surveillance of prostate cancer
- Adc
- ADE (chemotherapy)
- Adecatumumab
- Adegramotide
- Adjuvant therapy
- Adoptive cell transfer
- Advaxis
- AFP-07
- AFPep
- ALECSAT
- ALK inhibitor
- Alpelisib
- Alternating electric field therapy
- Alternative cancer treatments
- Amatuximab
- AMG 319
- Amphinex
- Angiostatin
- Annamycin
- Anti-idiotypic vaccine
- Anti-VEGF
- Antibody–drug conjugate
- Antihormone therapy
- Template:Antineoplastic-agents-stub
- Asandeutertinib
- Asparaginase erwinia chrysanthemi
- ATC code L01
- Atrasentan
- Auger therapy
- Autologous immune enhancement therapy
- Autologous tumor cell
- Avapritinib
- Avicine
- Axicabtagene ciloleucel
B
- Bavituximab
- Belantamab mafodotin
- Belvarafenib
- Bempegaldesleukin
- Berzosertib
- BI 811283
- Bi-specific T-cell engager
- Binimetinib
- Biologic Response Modifiers
- Bivatuzumab
- Bivatuzumab mertansine
- Bland embolization
- Boron neutron capture therapeutics
- Brachytherapy
- Brexucabtagene autoleucel
- Brigatinib
- Brivanib alaninate
- Brontictuzumab
C
- Camidanlumab tesirine
- Cancer Chemotherapy and Pharmacology
- Cancer drugs
- Cancer Treatment
- Cantuzumab
- Cantuzumab mertansine
- Cantuzumab ravtansine
- Capmatinib
- Capsaicin
- CAR T cell
- CAR-302,196
- Carmustine
- Carotuximab
- Cellular adoptive immunotherapy
- Che
- Chemoimmunotherapy
- Chemosensitizer
- Chemotherapy
- Cirmtuzumab
- Cisplatin
- Citatuzumab bogatox
- Cixutumumab
- Clevegen
- Clostridium novyi-NT
- Cofetuzumab pelidotin
- Coley's toxins
- Conatumumab
- Continuous hyperthermic peritoneal perfusion
- Cryoimmunotherapy
- Custirsen
- Cyberknife (device)
- Cytarabine
D
E
- Ecromeximab
- Edodekin alfa
- Edrecolomab
- Electrochemotherapy
- Emactuzumab
- Enadenotucirev
- Enavatuzumab
- Encorafenib
- Endoscopic mucosal resection
- Endostatin
- Engineered CAR T cell delivery
- Enoblituzumab
- Ensituximab
- Epigenetic therapy
- Erlizumab
- Ertumaxomab
- Estrogen deprivation therapy
- Etoposide
- Exagamglogene autotemcel
F
G
H
I
- Icrucumab
- Idecabtagene vicleucel
- Ifinatamab deruxtecan
- Image-guided radiation therapy
- IMEP (chemotherapy)
- Imexon
- IMM-101
- Immunotoxin
- Infigratinib
- Insulin potentiation therapy
- Internal radiation therapy
- Intetumumab
- Intraoperative electron radiation therapy
- Intraoperative radiation therapy
- Iratumumab
- IRGD peptides
- Irreversible electroporation
- Isolated organ perfusion technique
L
- Labetuzumab
- Leronlimab
- Lexatumumab
- Liarozole
- Limb perfusion
- Linifanib
- Linrodostat
- Lintuzumab
- Liposomal daunorubicin
- Lirentelimab
- Lirilumab
- Lisocabtagene maraleucel
- List of chemotherapeutic agents
- List of drugs: Y
- List of hormonal cytostatic antineoplastic agents
- Lomustine
- Loncastuximab tesirine
- Lorlatinib
- Lorvotuzumab mertansine
- Low-dose chemotherapy
- Lucatumumab
